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Background: With the increasing prevalence of coronary artery disease, percutaneous
coronary artery procedures have become even more important. Our study has compared
transradial to transfemoral artery approach for coronary procedures in Indian population.
Aims and objective: Comparison of transradial and transfemoral artery approach for
percutaneous coronary procedures.
Material & methods: 26,238 patients, who underwent percutaneous coronary artery pro-
cedures, were divided into two groups depending upon transradial and transfemoral artery
approach and compared for the various demographic and clinical characteristics, risk
factors profile, vascular access and procedural details.
Results: 26,238 patients underwent percutaneous coronary procedures at our center. 81%
were male and 19% were female. 55.65% and 44.35% procedures were done through
transfemoral and transradial approach, respectively. 17,417 (66.38%) coronary angiogra-
phies were done, out of which 53.92% were transradial and 46.08% were transfemoral
procedures. 8821 (33.62%) Percutaneous Transluminal Coronary Angioplasty (PTCA) were
done, out of which 25.46% and 74.54% were done through transradial and transfemoral
approach, respectively. Mean fluoroscopy time was 4.40  3.55 min for transradial and
3.30  3.66 min for transfemoral CAG (p < 0.001). For PTCA mean fluoroscopy time was
13.53  2.53 min for transradial and 12.61  9.524 min for transfemoral PTCA (p < 0.001).
Minor and major procedure related complications and total duration of hospital stay were
lower in transradial as compared to transfemoral group.127; fax: þ91 (0) 522 2668573.
(S. Tewari).
2013, Cardiological Society of India. All rights reserved.
i n d i a n h e a r t j o u rn a l 6 5 ( 2 0 1 3 ) 3 7 8e3 8 7 379Conclusion: The number of percutaneous transradial procedures have increased signifi-
cantly with reduced complication rates and comparable success rate to transfemoral
approach, along with the additional benefits to patient in terms of patient comfort, pref-
erence and reduced cost of health delivery.
Copyright ª 2013, Cardiological Society of India. All rights reserved.1. Introduction access site or retroperitoneal bleeding or requiring adminis-Coronary catheterization is usually performed via the trans-
femoral approach. Transradial access offers advantages in
comparison with transfemoral access, especially under con-
ditions of aggressive anticoagulation and antiplatelet treat-
ment in which bleeding complications at the femoral
puncture site can result in increased morbidity and duration
of hospitalization.1 Therefore, the rationale for the transradial
approach is the intention to reduce access site bleeding
complications, earlier ambulation, and improved patient
comfort.2e4 Transradial procedures have been demonstrated
to be an effective and safe alternative to transfemoral pro-
cedures. Safety of transradial coronary catheterization is
mainly determined by the favorable anatomic relations of the
radial artery to its surrounding structures, like no major veins
or nerves located near the artery, hence minimizing the
chance of injury of these structures. Superficial course of the
radial artery gives the advantage of easy hemostasis by local
compression. Thrombotic or traumatic arterial occlusion does
not endanger the viability of the hand if adequate collateral
blood supply from the ulnar artery is present. Multiple studies
have demonstrated that bleeding complications after PTCA
can be substantially reduced with transradial access.
Furthermore, transradial primary success rates, even in high-
risk groups, are similar to those from the femoral approach.5,62. Methods
Data of 26,238 patients were collected who underwent coro-
nary angiography and angioplasty during the study period
from April 2004 to December 2011 at our center. The center
has multiple operators and most of the coronary procedures
are done through radial approach. Data was thoroughly
analyzed comparing various study variables between trans-
radial and transfemoral groups. Successful vascular access,
coronary cannulation, entry site complications, asymptom-
atic loss of radial pulsations, procedural and fluoroscopy
times, PTCA success, and length of hospital stay were
compared.
An access site related endpoint was defined as either the
necessity to puncture a second access site due to any proce-
dural failure or a major access site complication. American
College of Cardiology database definitions for vascular com-
plications were used to define the complications as minor or
major.7 Minor vascular complications were defined as any of
the following: hematoma <10 cm, arteriovenous fistulae, or
pseudoaneurysm. Major vascular complications were defined
as death caused by vascular complications, vascular repair,
major vascular bleeding (>3 g hemoglobin decrease because oftration of blood transfusions or vascular repair, alone or in
combination), vessel occlusion, or loss of pulse.7,8 After a
failed attempt to cannulate the coronary artery, the operator
was free to select any other entry site. This site could be the
same artery at the contralateral side or any other artery.
Procedure-related endpoints were defined as successful
completion of the procedure from the first accessed puncture
site, occurrence of any major cardiac event like death,
myocardial infarction, coronary artery bypass graft surgery or
repeat PTCA.
2.1. Patient selection
In order to assess the safety, feasibility, and efficacy of
transradial catheterization, we retrospectively analyzed the
patient database of our cardiac catheterization laboratory of
seven years from a period of April 2004 to December 2011, in a
tertiary care hospital. All patients who had underwent coro-
nary catheterization procedures both diagnostic and thera-
peutic were included in the study.
2.2. Vascular access
Selection of the access site was individualized according to
the preference of the operator and appropriateness of radial or
femoral artery pulsations. Crossover from one arterial site to
another was permitted at any time at the physician’s discre-
tion. Radial and femoral artery access were secured using the
standard protocol and acceptable practice. Radial sheaths for
diagnostic and interventional procedures had a diameter of 5-
and 6-F, respectively, whereas 7-F radial sheaths were used in
few patients with bifurcation lesions. Similarly for trans-
femoral access, 6-F sheaths were used for diagnostic pro-
cedures and 7-F sheaths were used for interventional
procedures. Anticoagulation after sheath insertion was ob-
tained using the standard practice guidelines. Unfractionated
heparin with a target activated clotting time of 200e250 s if
used in conjunction with glycoprotein (GP) IIb/IIIa inhibitors,
or 250 to 300 s otherwise. Patients in the study received GP
IIb/IIIa receptor inhibition also according to usual protocol
with abciximab or tirofiban. Post-PTCA, patients were treated
with aspirin and clopidogrel in a routine manner. Access site
evaluation was routinely done after the procedure and before
discharge.
2.3. Hemostatsis
Arterial sheaths were removed immediately after diagnostic
or interventional transradial procedures while still being
anticoagulated. Hemostasis after diagnostic transradial
i n d i a n h e a r t j o u r n a l 6 5 ( 2 0 1 3 ) 3 7 8e3 8 7380coronary angiography was obtained using a pressure bandage
with 2 elastic sticky straps immediately applied to the punc-
ture site without a period of manual compression. In patients
who underwent transradial angioplasty, hemostasis was
achieved by immediate removal of vascular sheath and
application of TR band, which was gradually loosened and
removed after ACT < 180 s was achieved. The average time
duration of TR band application varied widely but was less
than 4-6 h in most patients.
In case of transfemoral diagnostic catheterization, the
sheaths were removed in the catheterization laboratory, and
hemostasis was obtained by manual compression. A bandage
was applied, and the patients were restricted to bed rest for
6 h. After an interventional procedure via the transfemoral
approach, hemostasis was achieved by sheath removal after
activated clotting time (ACT) declined to <180 s followed by
manual compression followed by a bandage for an additional
period of 6 h.3. Study variables
Data was analyzed for the demographic profile of the patient
population including age, gender, height, weight, body mass
index (BMI) and cardiovascular risks like hypertension, dia-
betes, dyslipidemia, smoking, family history of premature
CAD. The access site complications which included access
failure, minor hematomas, major hematoma, loss of distal or
radial pulse, cross over to another access site and procedural
details which included procedural success rate, fluoroscopy
time and duration of hospital stay were studied. Additionally,
vascular access site complications during hospitalization, like
pseudoaneurysm, arteriovenous fistula, retroperitoneal he-
matoma, limb ischemia, surgical vascular repair were recor-
ded. PTCA-related endpoints were defined as a residual
stenosis > 50% or the occurrence of any major cardiac event:
death, myocardial infarction, coronary artery bypass graft
surgery or repeat PTCA during the same hospital admission.Table 1 e Baseline characteristics of patients.
Total 26238
(100%)
Tr
Age 56.80  9.86
Male:Female 81%:19%
BMI (kg/m2) 24.10  3.36
CV risk factors:
Smoking 5674 (21.63)
Dyslipidemia 8191 (31.22)
Diabetes 8664 (33.02)
Hypertension 12144 (46.28)
Family history 1183 (4.51)
Diagnosis:
Chronic stable angina 5911 (22.53%)
Unstable angina 7470 (28.47%)
Acute/recent MI 9535 (36.74%)
Post CABG 824 (3.14%)
Mean fluoroscopy time (min) 7.12  7.40
Crossover to contralateral access site 67 (0.25%)
Crossover to another access site 125 (0.48%)4. Statistical analysis
Data were entered into a computerized database in Microsoft
office excel sheets and was analyzed using SPSS 16.0 for
Windows (SPSS Inc., Chicago, Illinois). Absolute numbers and
percentages were computed to describe the patient popula-
tion. Continuous variables are expressed as mean  SD and
are compared using the student’s t test between the study
groups. Categorical variables are expressed as absolute
numbers or as percentages and were compared between the
two groups using chi-square test. Value of p < 0.05 was
considered to be statistically significant.5. Results
5.1. Analysis of entire study population
From April 2004 to December 2011, a total of 26,238 patients
underwent percutaneous coronary artery procedures
including angiography and angioplasty through transradial
and transfemoral approach. 14601 (55.65%) patients under-
went procedures through transfemoral approach and 11637
(44.35%) patients had procedures done through transradial
route. All of these patients had either palpable femoral and/or
radial pulses. Baseline and demographic features of the
patients are depicted in Table 1. There were no statistical
differences between the transfemoral and transradial groups
in terms of mean age, male:female ratio, body mass index,
cardiovascular risk factors (smoking, hypertension, diabetes,
hypercholesterolemia, family history of CAD), or in clinical
presentation. However, we found that the post CABG (coro-
nary artery bypass surgery) patients had significantly higher
rate of transfemoral procedures as compared to transradial
(p < 0.001). The mean fluoroscopy time for all the transradial
procedures was significantly more than that for transfemoral
procedures (p < 0.001). A total of 67 (0.25%) patients needed toansfemoral 14601
(55.65%)
Transradial 11637
(44.35%)
p Value
56.99  10.01 56.55  9.66 NS
81%:19% 81%:19% NS
24.03  3.35 24.11  3.36 NS
3149 (21.57%) 2525 (21.7%) NS
4402 (30.15%) 3789 (32.56%) NS
4831 (33.09%) 3833 (33.94%) NS
6686 (45.79%) 5458 (46.90%) NS
662 (4.53%) 521 (4.47%) NS
3349 (22.94%) 2562 (22.02%) NS
4105 (28.11%) 3365 (28.91%) NS
5571 (38.16%) 3964 (34.06%) NS
811 (5.55%) 13 (0.11%) <0.001
6.24  6.13 7.83  8.21 <0.001
19 (0.13%) 48 (0.41%) <0.001
5 (0.03%) 122 (1.05%) <0.001
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secure the primary site of arterial access. Out of these 19
(0.13%) of all the patients in transfemoral group required to be
shifted to left femoral from right femoral artery access site
and 48 (0.41%) patients in transradial group were transferred
to contralateral access site. The difference was statistically
significant (p < 0.001). 125 (0.48%) of all the patients, were
transferred to another access sitewhichwere 5 (0.03%) in from
transfemoral to transradial site and 122 (1.05%) from trans-
radial to transfemoral approach. The difference was statisti-
cally significant (p < 0.001).
5.2. Analysis of diagnostic procedures
Total of 17,417 (66.4%) coronary angiographies (CAG) were
done, out of which 9391 (53.92%) were done through trans-
radial route and 8026 (46.08%) were done through trans-
femoral approach.
The demographic and baseline characteristics of the pa-
tients who underwent diagnostic coronary procedure are
summarized in Table 2. There was no significant difference in
terms of mean age, gender distribution, BMI, cardiovascular
risk profile of the patients between the two diagnostic group.
The mean total fluoroscopy time (FT) for all the CAG was
4.36  3.96 min. Transradial CAG had longer FT
(4.40  3.55 min) than transfemoral CAG (3.89  3.65 min) and
the difference was statistically significant (p < 0.001). But once
the access had been taken the procedural success for CAGwas
comparable between the two groups with CAG success rate ofTable 2 e Procedural data for diagnostic procedures.
Transfemoral 8026 (4
Demographic profile:
Age 56.82  7.1
Male:Female 80:20%
BMI 24.11  3.37
CV risk factors:
Smoking 1679 (20.96%)
Dyslipidemia 2363 (29.51%)
Diabetes 2675 (33.40%)
Hypertension 3702 (46.23%)
Family history 381 (4.75%)
Mean fluoroscopy time for CAG (min) 3.89  3.65
Crossover to contralateral access site 11 (0.1%)
Crossover to another access site 2 (0.02%)
Complications:
Radial artery spasm 0
Minor hematomas 92 (1.1%)
Major hematoma 0
Loss of distal/radial pulse 1 (0.01%)
Radial artery spasm e
Pseudoaneurysm 4 (0.04%)
Arteriovenous fistula 0
Retroperitoneal hematoma 0
Limb ischemia 0
Surgical vascular repair 0
Major bleeding 0
CVA/TIA 1
Hospital Stay (days) 1.9  0.8
Mortality 099.9% in transfemoral group and 99.6% in transradial group
(p ¼ 0.04). The primary access site intended could not be
secured in 0.12% and 1.16% of the patients in transfemoral and
transradial procedures, respectively and the difference was
statistically significant (p < 0.001). Transradial CAG group
required more number of patients to be shifted to contralat-
eral as compared to transfemoral group, [22 (0.23%) vs. 11
(0.13%), p¼ 0.164] and also to another access site [87 (0.93%) vs.
2 (0.02%), p < 0.001] because of inability to access the primary
intended site because of different reasons. The difference
between them found to be significant.
1.1% of the patients undergoing transfemoral CAG had
minor hematoma at entry site, while 0.75% of the patients in
diagnostic transradial group had entry site complications
except for repeated attempts for the arterial access. These
minor hematomas were managed conservatively. Radial
artery spasm was found in 187 (2%) patients undergoing
transradial CAG, which was managed conservatively in most
of the patients with repeat dose of intraarterial and intrave-
nous cocktail (mixture of lignocaine, diltiazem and nitro-
glycerine). The rate of spasm was more in patients who were
of female gender, short stature, required prolonged proce-
dural time due to technical difficulty and multiple catheter
exchanges. In a few patients, access site was needed to be
changed to either contralateral or another site. Four patients
in transfemoral group developed pseudoaneurysm at punc-
ture site, which were managed conservatively with ultra-
sound-guided compression without the need of surgery. Four
patients, one in transfemoral group and three in transradial6.08%) Transradial 9391 (53.92%) p Value
56.94  9.51 NS
79.5: 20.5% NS
24.09  3.35 NS
2051 (21.84%) NS
3022 (32.17%) NS
3068 (32.66%) NS
4383 (46.68%) NS
419 (4.46%) NS
4.40  3.55 <0.001
22 (0.23%) NS
87 (0.93%) <0.001
187 (2%) <0.001
71 (0.75%) <0.001
0
93 (0.01%) <0.001
141 (1.5%) <0.001
0 NS
0 e
0 e
0 e
0 e
0 e
3 e
1.1  0.6 NS
0 e
Table 4 e Results of diagnostic procedures.
Number % of total PTCA
(n ¼ 8821)
Normal coronary arteries 1637 9.4%
Slow flow 540 3.1%
Obstructive CAD 15240 87.5%
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which recovered over period of next 1e2 days without any
residual deficit. The mean duration of hospital stay was
shorter in transradial group (1.1  0.6 days) as compared to
transfemoral (1.9  0.8 days).
5.3. Analysis of interventional procedures
Total of 8821 (33.62%) PTCA were done, out of which 2246
(25.46%) were done through transradial route and 6575
(74.54%) were done through transfemoral approach. The
baseline characteristic, demographic profile and procedural
details are depicted in Table 3. The baseline characteristics of
the patient including age, gender distribution, BMI and car-
diovascular risk profile were not significantly different
amongst transfemoral and transradial groups. Transradial
PTCA had longer fluoroscopy time (13.53  2.53 min) as
compared to transfemoral PTCA (12.61  9.5 min) and the
difference was statistically significant (p < 0.001). 8 (0.12%)
patients in transfemoral group and 26 (1.17%) in transradial
group required changing of the access site to contralateral site
due inability to complete the procedure at various stages
(p < 0.001). Whereas 3 (0.04%) and 35 (1.57%) patients required
shifting to another access site in transfemoral and transradial
group, respectively (p < 0.001). PTCA success rate was com-
parable between the two groups (99.6% vs. 98.1%). Rate of
radial artery spasm was more in intervention group as
compared to CAG group (2% vs. 7.5%). Out of these 167 pa-
tients, most of the spasms were non procedure limiting andTable 3 e Procedural data for Interventional procedures.
Transfemoral 6575 (7
Age 56.81  9.71
Male:Female 84:16%
BMI 24.02  3.35
Smoking 1464
Dyslipidemia 2033
Diabetes 2145
Hypertension 2977
Family history 281
Mean fluoroscopy time (minutes) 12.61  9.52
Crossover to contralateral access site 8 (0.12%)
Crossover to another access site 3 (0.04%)
Complications:
Access failure 7 (0.11%)
Access site success 99.9%
PTCA success 99.6%
Minor hematomas 52 (0.8%)
Major hematoma 13 (0.2%)
Loss of distal/radial pulse 11 (0.16%)
Radial artery spasm 0
Pseudoaneurysm 9 (0.14%)
Arteriovenous fistula 0
Retroperitoneal hematoma 1 (0.015%)
Limb ischemia 1 (0.015%)
Surgical vascular repair 10 (0.15%)
Major bleedings 16 (0.24%)
CVA/TIA 3 (0.05%)
Hospital Stay (days) 2.2  3.1
Mortality 3managed conservatively, while few patients required shifting
of access to another site. The rate of minor hematomas were
0.8% in transfemoral group as compared to 0.5% in transradial
group. 0.2% of the patients in the transfemoral group had
major entry site hematoma with significant drop in hemo-
globin and were managed conservatively with extended
compression and blood transfusions. 11 (0.16%) of the patients
in transfemoral group had post procedure distal pulse loss.
Two patients in transfemoral group had limb ischemia, one of
which required surgical vascular repair including embolec-
tomy and another needed limb amputation. The loss of radial
artery pulse after the procedure was 5.34% after PTCA using 6-
F sheaths. None of these patients had ischemic complication
of upper extremity. One patient required vascular repair of the
radial artery for avulsion. One patient had retroperitoneal
hematoma after transfemoral PTCA, which was managed
conservatively. Major bleeding including entry site and other
sites (gastrointestinal, intracranial, urinary) was found in 16
(0.24%) of the patients undergoing PTCA through transfemoral
approach. Three patients in transfemoral PTCA group and 24.54%) Transradial 2246 (25.46%) p Value
56.97  9.70 NS
86:14% NS
24.06  3.34 NS
480 NS
774 NS
771 NS
1084 NS
102 NS
13.53  8.53 <0.001
26 (1.16%) <0.001
35 (1.56%) <0.001
38 (1.7%) <0.001
98.3% NS
98.1% NS
28 (1.2%) 0.150
4 (0.18%) 0.49
120 (5.34%) <0.001
167 (7.5%) <0.001
0 NS
0 e
0 NS
0 NS
2 (0.09%) NS
2 (0.09%) NS
2 (0.09%) NS
1.6  2.4 NS
5 NS
Fig. 2 e Year wise trend of total number of cases of
interventional procedures through transfemoral and
transradial route.
Table 5 e Vessel wise distribution of interventional
procedures.
Vessel Number % of total PTCA (n ¼ 8821)
Single vessel 6989 79.22%
Double vessel 1705 19.32%
Triple vessel 128 1.45%
Left main 31 0.35%
D1 147 1.66%
LAD 5108 57.90%
RAMUS 167 1.89%
LCX 1839 20.84%
OM 536 6.07%
RCA 2895 32.81%
PDA 34 0.38%
PLV 10 0.11%
SVG 6 0.06%
LAD graft 4 0.04%
OM graft 2 0.02%
RCA graft 11 0.12%
i n d i a n h e a r t j o u rn a l 6 5 ( 2 0 1 3 ) 3 7 8e3 8 7 383patients in transradial group had transient neurological deficit
post procedure, which improved over the course of the hos-
pital stay. The mean hospital stay of the patients undergoing
PTCA through femoral approach was 2.2  3.1 days as
compared to 1.6  2.4 days in patients of transradial group.
Majority of the stenting done were conventional, preceded by
balloon dilation of the lesion. Conventional stenting in
transfemoral group and transradial group was done in 99.7%
and 99.8% patients, respectively, whereas direct stenting was
done in 0.3% and 0.2% patients, respectively.
The angiographic data of the result of CAG shown in
Table 4 and vessel wise distribution of the interventional
procedures is shown in Table 5. Of all the interventional pro-
cedures (n ¼ 8821), 79% were single vessel PTCA of which LAD
was the most common vessel (58%). Approach wise distribu-
tion of the vessels is depicted in Table 5, which shows that
there were no significant difference between the interven-
tional approach for single vessel, double vessel, triple vessel
PTCA (79%,19%, 1.3% vs. 80%, 19%, 1.9%) between trans-
femoral and transradial group. However, we found that except
one, all the PTCA of CABG grafts including LIMA (left internal
mammary artery) and SVG’s (saphenous venous grafts) were
done through transfemoral approach (Table 6).
We also appreciated the significant increase in trend to-
wards the transradial approach for both diagnostic andFig. 1 e Year wise trend of total number of cases of
diagnostic procedures through transfemoral and
transradial route.interventional procedures over the study period of seven
years which has been depicted in Table 7, Figs. 1 and 2.
The FT, which is the key determinant of the radiation
exposure and may be a marker of the operators expertise,
decreased significantly in transradial diagnostic group over a
period of seven years. But in transfemoral diagnostic, trans-
femoral interventional and transradial interventional groups,
it did not show any significant difference. This may be
explained by increasing complexity of the procedures, which
are being done with increasing expertise. The trends of FT of
over the seven years is depicted in Table 8, Figs. 3 and 4.
Successful PTCA was achieved in 99.6% and 98.1% of pa-
tients who underwent PTCA through transfemoral and
transradial, respectively. The reasons for failed PTCA in radial
group and femoral group were inability to cross stenosis,
suboptimal results, side branch occlusion, partial success in
multivessel disease and coronary spasm. No significant dif-
ferences were noted between the reasons for PTCA failure
among the two groups. The total study mortality were five in
the radial group and three in the femoral group and were due
to severe left ventricular dysfunction and hemodynamic
instability.
Radial artery occlusion was not found in patients under-
going CAGwith 5 F sheath but was found in 120 patients (5.4%)Table 6 e Approach wise distribution of vessels.
Transfemoral Transradial
Single vessel 5218 (79.13%) 1769 (79.54%)
Double vessel 1291 (19.57%) 412 (18.52%)
Triple vessel 85 (1.28%) 43 (1.93%)
Left main 25 (0.38%) 7 (0.31%)
LAD 3794 (57.53%) 1295 (58.22%)
Diagonal 111 (1.68%) 36 (1.61%)
Ramus 124 (1.88%) 43 (1.93%)
LCx 1393 (21.12%) 449 (20.18%)
OM 377 (5.71%) 159 (7.14%)
RCA 2173 (32.95%) 718 (32.38%)
PDA 22 (0.33%) 12 (0.53%)
PLV 8 (0.12%) 2 (0.08%)
LAD graft 3 1
OM graft 6 e
RCA graft 14 e
Table 7 e Increasing use of transradial approach over
years.
Transfemoral
CAG
Transradial
CAG
Transfemoral
PCI
Transradial
PCI
2004 985 208 548 44
2005 1480 470 857 62
2006 1502 771 1025 53
2007 1142 1202 1016 67
2008 968 1439 996 203
2009 884 1777 1080 315
2010 556 1814 652 698
2011 490 1610 420 783
Fig. 3 e Trends of FT of transradial and transfemoral
diagnostic procedures over seven years.
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through 6-F sheath.
The hospital stay was significantly shorter with the
transradial procedures as compared to transfemoral pro-
cedures. Patient who underwent CAG through transfemoral
approach had mean hospital stay of 1.9  0.8 days as
compared to those who had transradial CAG and had hospital
stay of 1.1 0.6 days. In the PTCA arm, themean hospital stay
for transfemoral approach was 2.2  3.1 while in transradial
group it was 1.6  2.4 days. In our study, it was observed that
the patients who underwent transradial procedures had early
mobilization and lesser total cost of the procedure due to
shorter hospital stay.6. Discussion
Coronary interventions have become an essential part in the
management of patients with CAD. Percutaneous coronary
procedures are usually performed via the transfemoral
approach. Transradial access for coronary artery catheteri-
zation has several advantages in comparison with the trans-
femoral route. Bleeding complications at the femoral
puncture site can result in increased morbidity and duration
of hospitalization.1 Transradial approach reduces access site
bleeding complications, allows earlier ambulation, and im-
proves patient comfort.2e4 The near elimination of bleeding
complications makes the radial artery a safe entry site for
coronary procedures in patients with normal Allen test re-
sults. Outpatient treatment is a powerful tool for coping with
an increasing patient load in an unchanging hospital envi-
ronment and for reducing long waiting lists for coronary an-
gioplasty. The feasibility of transradial coronary stenting onTable 8 e Trend of fluoroscopy time (min).
Total CART TF CART TR CART
2004 4.23  3.48 3.59  3.03 6.17  3.98
2005 3.82  3.23 3.52  2.93 4.75  3.90
2006 3.93  3.05 3.72  3.06 4.35  2.99
2007 4.23  3.63 3.86  3.66 4.59  3.56
2008 4.19  2.70 3.99  2.85 4.33  3.36
2009 4.03  3.69 4.00  3.90 4.05  3.48
2010 4.43  3.85 4.67  4.83 4.35  3.57
2011 4.89  4.76 4.93  5.95 4.87  4.34an outpatient basis has been demonstrated in 100 patients.9
The safety and efficacy of transradial CAG and angioplasty
in the same setting have been demonstrated by Barbeau
et al in a group of 250 consecutive patients with normal Allen
test results, of whom 129 (51.6%) had subsequent balloon
angioplasty and 27 (10.8%) coronary stent implantation.10
Barbeau et al concluded that this approach could be ideal in
outpatient for adhoc invasive coronary interventions. This
patient-friendly strategy additionally decreases the costs of
health delivery. Thus, despite the higher incidence
of transradial coronary cannulation failure than with the 6F
transfemoral approach, the transradial approach is a good
routine technique for coronary procedures because of high
procedural success rates and PTCA outcomes similar to those
for 6F transfemoral PTCA, together with nearly complete
elimination ofmajor bleeding complications. Major additional
arguments are increased patient comfort and preference,
reduced postprocedural workload associated with the
achievement of hemostasis and the potential for outpatient
treatment. Factors probably contributing to the low incidence
of vascular complications are small-sized sheaths, use of
5000 IU of heparin during uncomplicated procedures and
immediate sheath removal.
In our study, we observed that the successful access site
was secured in 99.98% of the patients in transfemoral diag-
nostic group and 99.07% of the patients in transradial diag-
nostic group, whereas the similar rates in interventional
group were 99.06% and 98.44%, respectively. In a study done
by Martin Brueck et al including 1024 patients undergoing
coronary catheterization, successful catheterization wasTotal PTCA TF PTCA TR PTCA
12.22  8.11 12.10  7.68 15.08  11.59
12.22  8.63 12.24  8.57 11.90  9.53
11.56  8.24 11.62  8.35 10.25  5.59
11.99  7.90 12.05  7.97 10.97  6.68
12.02  8.75 11.98  9.17 12.20  6.32
13.33  10.42 13.31  10.46 13.37  8.34
14.01  12.45 14.67  11.77 13.40  9.60
14.64  9.24 14.56  10.36 14.69  8.57
Fig. 4 e Trends of fluoroscopy time of transradial and
transfemoral interventional procedures over seven years.
i n d i a n h e a r t j o u rn a l 6 5 ( 2 0 1 3 ) 3 7 8e3 8 7 385achieved in 96.5% of 512 patients in the transradial group and
in 99.8% of 512 patient in the transfemoral group.11 Trans-
femoral approach had higher access site success rate as
compared to transradial approach, the difference being sta-
tistically insignificant (p ¼ 1.000, ns).
We found that in the diagnostic group, the primary access
site intended could not be secured in 0.12% and 1.16% of the
patients in transfemoral and transradial procedures, respec-
tively and transradial CAG group required more number of
patients to be shifted to contralateral as compared to trans-
femoral group, [(0.23% vs. 0.13%), p ¼ 0.164] and also to
another access site [(0.93%) vs. (0.02%), p < 0.001] because of
inability to access the primary intended site because of
different reasons. The difference between them was found to
be significant. In the intervention group, 0.12% patients in
transfemoral group and 1.17% in transradial group required
changing of the access site to contralateral site due inability to
complete the procedure at various stages (p < 0.001). Whereas
3 (0.04%) and 35 (1.57%) patients required shifting to another
access site in transfemoral and transradial group, respectively
which was significant (p < 0.001). The failed attempts in
transradial group were due to radial artery puncture failure,
radial artery spasm, tortuosity of the innominate trunk, dila-
tation of the ascending aorta, lusoria artery and inability to
track the catheter in the left main. Martin Brueck et al
observed that 0.2% required crossover to the transradial ac-
cess because of an angiographically proven occlusion of the
abdominal aorta and 3.5% in the transradial group needed
crossover to femoral access site.11 In all cases, the procedure
was successfully performed by the transfemoral approach.
InMartin Brueck et al study, the largemajority of PCIs were
adhoc angioplasty (91.0% in the transradial group and 93.2% in
the transfemoral group; p ¼ 0.55).11 Overall success rate in PCI
was 99.5% in the femoral group and 96.6% in the transradial
group (p ¼ 0.06). There was 1 stent delivery failure due to a
tortuous coronary artery in the transfemoral group. Causes of
interventional failure in the transradial group were severe
radial artery spasm (n ¼ 3), tortuosity of the innominate trunk
(n ¼ 2), and impossible engagement of the left main (n ¼ 1)
requiring switch to the transfemoral, which was performed
successfully in all cases. The percentage of patients treated by
drug-eluting stent implantation was similar in both groups
(23.4% in the transradial group and 25.7% in the transfemoral
group; p ¼ 0.76).In our study themean total fluoroscopy time (FT) for all the
CAG was 4.36  3.96 min. Transradial CAG had significantly
longer FT than transfemoral CAG (4.40  3.55 min vs.
3.89  3.65 min, p < 0.001). Transradial PTCA had longer FT
(13.53  2.53 min) as compared to transfemoral PTCA
(12.61  9.5 min) and the difference was statistically signifi-
cant (p < 0.001). Martin Brueck et al also had similar findings
and had observed that the median fluoroscopic time was
significant longer (p ¼ 0.001) in the transradial group (9.0 min,
interquartile range i.e. IQR range 3.9e10.7min) comparedwith
the transfemoral group (5.8 min, IQR 1.7e7.5 min).
We, in our study, found that the access site related com-
plications were less in diagnostic group as compared to the
intervention group and also that the complications were less
in transradial group as compared to the transfemoral group.
Martin Brueck et al found that despite the usage of vascular
closure devices in 93.2% after transfemoral intervention,
vascular access site complications were higher in the trans-
femoral group (3.71%) compared with the transradial group
(0.58%; p ¼ 0.0008).11 Whereas in our study, we observed that
without using vascular closure device the total complication
rates in the diagnostic group were 1.15% and 4.26% in trans-
radial and transfemoral group, respectively. In the interven-
tional group the total complication rates were 1.8% and 14.5%
in the transfemoral and transradial group, respectively. The
higher complication rate in transradial cohort were mainly
due to radial artery spasm. In our study, pseudoaneurysms
were seen in none of the patients in transradial procedures,
which were similar to the results from Martin Brueck et al,
while 4 patients of transfemoral diagnostic and 9 patients of
transfemoral interventional group developed pseudoaneur-
ysmas compared to 3 patients after transfemoral procedure in
the study by Martin Brueck et al. All of them in our study were
successfully treated by ultrasound-guided compression.
In our cohort, two patients in transfemoral group had
limb ischemia, one of which required surgical vascular repair
including embolectomy and another needed limb amputa-
tion, whereas in study by Martin Brueck et al none of the
patients was sent to surgery due to procedural complica-
tions. In the transfemoral group, 63 (1.0%) patients developed
groin hematoma out of which 13 weremajor hematomas and
required blood transfusion, none of the patients in our study
could be detected to have developed arteriovenous fistula in
either groups as compared to 2 patients who suffered from
an arteriovenous fistula after diagnostic angiography that
was treated conservatively in the study by Martin Brueck
et al. 93 (0.01%) and 120 (5.34%) of the patients in the diag-
nostic and interventional group, respectively, had loss of
radial pulse at discharge as compared to only 3 patients
(0.59%) in the transradial group who had no beating radial
artery pulse at discharge without any evidence of forearm
ischemia in the study by Martin Brueck et al. No cases of
major vascular or bleeding complications occurred in the
transradial group. Three patients in transradial group and
two patients in the transfemoral group experienced peri-
procedural neurological deficit, while 4 patients suffered
from a transient ischemic attack that promptly resolved after
diagnostic coronary angiography, whereas one, during a PCI
procedure, had a stroke with left hemiplegia that was
managed conservatively.
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femoral approach for diagnostic catheterization and inter-
ventional procedures by Agostoni et al included 12 random-
ized trials (3224 patients).12 Major adverse cardiovascular
events were similar between transradial and transfemoral
groups (2.1 vs. 2.4%, 95% CI: 0.57e1.68; p¼ 0.7). The transradial
approach was superior to transfemoral approach in entry site
complications (0.3 vs. 2.8%; 95% CI 0.82 to 0.29; p < 0.001)
and lower total hospital charge. Conversely, transradial suc-
cess was associated with a significantly higher number of
procedural failures in comparison to femoral success (7.2 vs.
2.4%; p ¼ 0.001) and longer FT (8.9 vs. 7.8 min, p < 0.001).
In a study published by Patel et al, transradial route was
used successfully in 98.1% of the patients, while through
transfemoral route in 1.9% of the patients.13 73.6% patients
underwent CAG, while PCI was performed in 26.4% of the
patients. The mean age was 64.6  11.8 years and 76% were
men. In 3.9% patients, left radial approach was required. In
CAG, 9.9% had normal coronary arteries, 3.5% had slow flow
and 86.6% had obstructive coronary artery disease. Percuta-
neous intervention was attempted in 7083 lesions with
angiographic success rate being 97%. Direct stenting was
attempted in 58% of the patients and successfully performed
in 91%. The remaining lesions were predilated to complete the
procedure (overall success rate being 100%). Conventional
stenting (with pre dilation) and plain balloon/cutting balloon
angioplasty were attempted in 34% and 8% lesions, respec-
tively. The success rate of combined group was 96.2%. No
patient suffered from ischemia of the hand or impairment of
hand function. No patient had bleeding from the access site
and hence no blood transfusion was required. Minor hema-
tomas were observed in 0.8% of the patients. Hematoma
extending upto the mid forearm occurred in 0.1% of the pa-
tients. Major complications (CVA) observed in 0.03% of the
patients. Radial artery spasm and pain were noted in 8.55 and
4.8% patients, respectively. 0.7% had small pseudoaneurysm.
A meta-analysis of 18 randomized trials comparing trans-
radial approach vs. transfemoral approach that mainly
focused on elective patients undergoing coronary angiog-
raphy and/or adhoc intervention showed a 73% reduction of
access site bleeding complications and a trend toward a 29%
reduction of the ischemic composite endpoint of death,
myocardial infarction, or stroke in the transradial group.14
A systematic review of the literature involving 2808 STEMI
patients who were largely recruited via non-randomized
comparisons, showed that transradial intervention was
associated with a significant, almost 50% decrease of overall
mortality. Mortality in the 516 patients in whom access sites
were randomly allocated was also numerically almost 40%
lower in the transradial group, but this difference failed to
reach statistical significance.15
In the RIVAL (RadIal Vs femorAL access for coronary
intervention) study, patients randomized to the transradial
arm in the highest tertile for radial percutaneous coronary
intervention (PCI) center volume showed a 50% reduction of
death, myocardial infarction, or stroke compared with the
transfemoral group, which came along with a 55% reduction
of major bleeding complications.16 Interestingly, in the 1958
STEMI study patients, a 41% significant reduction of the
composite ischemic endpoint and a 61% reduction ofmortality alone were noted in the transradial group, suggest-
ing that this patient population may benefit relatively more
from a dedicated bleeding minimization strategy (16). An
alternative hypothesis thatmerits further investigation is that
only centers with high radial PCI volumes were confident in
randomizing STEMI patients in the study; therefore, STEMI
patients in the study may simply serve to identify operators
particularly experienced for transradial PCI.
A study by Marco Valgimigli et al suggests that the risks of
transitioning toward the transradial route over the conven-
tional transfemoral approach in STEMI patients, provided
the process is undertaken in a step-wise approach as part of a
global transradial intervention program, may be largely
outweighed by a lower mortality rate.17 Although a causal
relationship between the observed improved short-term
safety profile and the lower 2-year fatality rate was not
proven by this study (19), this hypothesis is of major poten-
tial relevance for the whole medical community, and it is
currently being tested in the MATRIX (Minimizing Adverse
haemorrhagic events by Transradial access site and systemic
Implementation of angioX) study. Finally, based on a sub-
stantial reduction in the length of hospitalization as well as
in access site bleeding and vascular complications the
widespread adoption of transradial intervention may
dramatically impact the economic burden of the developed
as well as developing countries.14,15 The RIFLE-STEACS
(Radial Versus Femoral Randomized Investigation in ST-
Elevation Acute Coronary Syndrome) was a multicenter,
randomized, parallel-group study.18 Between January 2009
and July 2011, 1001 acute ST-segment elevation acute coro-
nary syndrome patients undergoing primary/rescue PCI were
randomized to the radial (500) or femoral (501) approach at 4
high-volume centers. The primary endpoint was the 30-day
rate of net adverse clinical events (NACEs), defined as a
composite of cardiac death, stroke, myocardial infarction,
target lesion revascularization, and bleeding. Individual
components of NACEs and length of hospital stay were sec-
ondary end points. The primary endpoint of 30-day NACEs
occurred in 68 patients (13.6%) in the radial arm and 105
patients (21.0%) in the femoral arm (p ¼ 0.003). In particular,
compared with femoral, radial access was associated with
significantly lower rates of cardiac mortality (5.2% vs. 9.2%,
p ¼ 0.020), bleeding (7.8% vs. 12.2%, p ¼ 0.026), and shorter
hospital stay (5 days first to third quartile range, 4e7 days] vs.
6 [range, 5e8 days]; p¼ 0.03). This study concluded that radial
access in patients with ST-segment elevation acute coronary
syndrome is associated with significant clinical benefits, in
terms of both lower morbidity and cardiac mortality. Thus, it
should become the recommended approach in these pa-
tients, provided adequate operator and center expertise is
present.7. Study limitations
Our findings should be interpreted in the context of our study
design and its limitations. First, our study is retrospective and
data are observational. Second, there was a substantial use of
glycoprotein IIb/IIIa inhibitors in our study population.
Whether our observations are similarly valid also for patients
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mains to be determined. Bleeding events were not prospec-
tively collected in our study; therefore, red blood cell
transfusion and access site surgical repair was used as a
surrogate for major bleeding or vascular events. It remains to
be determinedwhether the reduction ofmyocardial infarction
and stroke at 2-year follow-up favoring the transradial
approach is a spurious finding or may reflect a true long-term
advantage of a strategy that minimizes bleeding and vascular
events. Finally, the use of secondary prevention medications
was not prospectively collected in our study. Therefore, we
cannot rule out the possibility that a less aggressive imple-
mentation of secondary prevention pharmacological mea-
sures in patients who experienced major in-hospital bleeding
and vascular events may at least partially explain the
observed association between transradial intervention and
improved cardiovascular outcomes. Our study design is a
retrospective and non-randomized study, a selection bias
cannot be ruled out. This present study reflects a real world
clinical setting of unselected consecutive patients. Finally, our
study represents a single-center experience.8. Conclusion
Transradial coronary catheterization is safe, feasible, effective
and nearly abolishes entry site complications, in comparison
with significantly higher rates in patients undergoing trans-
femoral catheterization. However, transradial access used to
be limited by a significantly higher rate of procedural failure
but with increasing expertise it has become as successful as
transfemoral approach. It does not allow the possibility of
using other devices such as intra-aortic balloon pump or to
perform PCI requiring 8-F catheters. However, radial artery
access almost abolishes complications at entry site in com-
parison with significantly higher rates in transfemoral
approach. The procedural duration (excluding hemostasis
period), fluoroscopy time, and radiation exposure are higher
compared with transfemoral access. Major additional benefits
with transradial approach like increased patient comfort and
preference and additional decrease in the cost of health
delivery guide us for a wider spectrum of therapeutic options
in the current era of increasing percutaneous coronary
procedures.Conflicts of interest
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